Ginkgo biloba extract (EGb 761) protects Na,K-ATPase activity during cerebral ischemia in mice

Neuroreport. 1999 Jan 18;10(1):47-51. doi: 10.1097/00001756-199901180-00009.

Abstract

Neuroprotective drugs such as Ginkgo biloba extract (EGb 761) could prevent the ischemia-induced impairment of the Na,K-ATPase activity. In this study, Na,K-ATPase activity and expression, contents in fatty acids and malondialdehyde, an index of lipoperoxidation, were compared in the ipsilateral (ischemic) and the contralateral (unlesioned) cortices after 1 h of unilateral focal cortices cerebral ischemia in the mouse. EGb 761 (110 mg/kg) was administered daily to half of the animals for 10 days before ischemia. Ischemia significantly reduced Na,K-ATPase activity by about 40% and increased malondialdehyde content; EGb 761 pretreatment abolished these effects. The free radical scavenger properties of EGb 761 are a potential mechanism by which Na,K-ATPase injury and lipoperoxidation are prevented.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fatty Acids / metabolism
  • Flavonoids / therapeutic use*
  • Free Radical Scavengers / therapeutic use
  • Ginkgo biloba*
  • Ischemic Attack, Transient / drug therapy*
  • Lipid Peroxidation / drug effects
  • Male
  • Malondialdehyde / metabolism
  • Mice
  • Neuroprotective Agents / therapeutic use*
  • Plant Extracts / therapeutic use*
  • Plants, Medicinal*
  • Sodium-Potassium-Exchanging ATPase / drug effects*

Substances

  • Fatty Acids
  • Flavonoids
  • Free Radical Scavengers
  • Neuroprotective Agents
  • Plant Extracts
  • Ginkgo biloba extract
  • Malondialdehyde
  • Sodium-Potassium-Exchanging ATPase